SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-014851
Filing Date
2019-05-01
Accepted
2019-05-01 16:33:04
Documents
3
Period of Report
2019-04-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vtvt-8k_20190429.htm 8-K 60006
2 EX-99.1 vtvt-ex991_6.htm EX-99.1 340514
3 GRAPHIC gepbu3pt3clp000001.jpg GRAPHIC 13695
  Complete submission text file 0001564590-19-014851.txt   420806
Mailing Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265
Business Address 4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37524 | Film No.: 19788084
SIC: 2834 Pharmaceutical Preparations